Terms: = Skin cancer AND WT1, WAGR, 7490, ENSG00000184937, WT33, GUD, WIT-2 AND Treatment
15 results:
1. Locally advanced choroidal melanoma with favorable molecular prognosis - case report.
Bălăşoiu AT; Ştefănescu-Dima AŞ; Bălăşoiu M; Ciurea RN; Muraru A; Dan AO; Simionescu CE
Rom J Morphol Embryol; 2022; 63(4):645-652. PubMed ID: 36808200
[TBL] [Abstract] [Full Text] [Related]
2. Giant benign lymphangioendothelioma with positive expression of Wilms tumor 1: A case report.
Teixeira D; Canelhas Á; Costa M; Magalhães C; Ferreira EO; César A
J Cutan Pathol; 2022 Jan; 49(1):86-89. PubMed ID: 34423872
[TBL] [Abstract] [Full Text] [Related]
3. New mutation in wt1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
Akramov NR; Shavaliev RF; Osipova IV
Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
[TBL] [Abstract] [Full Text] [Related]
4. Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrum.
Brčić I; Brodowicz T; Cerroni L; Kashofer K; Serbanescu GL; Kasseroler MT; Amann G; Scheipl S; Szkandera J; Leithner A; Liegl-Atzwanger B
Pathology; 2020 Feb; 52(2):236-242. PubMed ID: 31870501
[TBL] [Abstract] [Full Text] [Related]
5. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract] [Full Text] [Related]
6. Selective Inhibition of HIF1α Expression by ZnSO
Burián Z; Ladányi A; Barbai T; Piurkó V; Garay T; Rásó E; Tímár J
Pathol Oncol Res; 2020 Apr; 26(2):673-679. PubMed ID: 30613921
[TBL] [Abstract] [Full Text] [Related]
7. Feasibility and Immune Response of wt1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.
Hirabayashi K; Yanagisawa R; Saito S; Higuchi Y; Koya T; Sano K; Koido S; Okamoto M; Sugiyama H; Nakazawa Y; Shimodaira S
Anticancer Res; 2018 Apr; 38(4):2227-2234. PubMed ID: 29599343
[TBL] [Abstract] [Full Text] [Related]
8. Vascular Tumors in Infants: Case Report and Review of Clinical, Histopathologic, and Immunohistochemical Characteristics of Infantile Hemangioma, Pyogenic Granuloma, Noninvoluting Congenital Hemangioma, Tufted Angioma, and Kaposiform Hemangioendothelioma.
Johnson EF; Davis DM; Tollefson MM; Fritchie K; Gibson LE
Am J Dermatopathol; 2018 Apr; 40(4):231-239. PubMed ID: 29561329
[TBL] [Abstract] [Full Text] [Related]
9. Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.
Shah NN; Loeb DM; Khuu H; Stroncek D; Ariyo T; Raffeld M; Delbrook C; Mackall CL; Wayne AS; Fry TJ
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2149-2154. PubMed ID: 27634018
[TBL] [Abstract] [Full Text] [Related]
10. A single plan solution to chest wall radiotherapy with bolus?
Ordonez-Sanz C; Bowles S; Hirst A; MacDougall ND
Br J Radiol; 2014 May; 87(1037):20140035. PubMed ID: 24646288
[TBL] [Abstract] [Full Text] [Related]
11. α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial.
Akiyama Y; Oshita C; Kume A; Iizuka A; Miyata H; Komiyama M; Ashizawa T; Yagoto M; Abe Y; Mitsuya K; Watanabe R; Sugino T; Yamaguchi K; Nakasu Y
BMC Cancer; 2012 Dec; 12():623. PubMed ID: 23270484
[TBL] [Abstract] [Full Text] [Related]
12. wt1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: a phase II trial.
Miyatake T; Ueda Y; Morimoto A; Enomoto T; Nishida S; Shirakata T; Oka Y; Tsuboi A; Oji Y; Hosen N; Nakatsuka S; Morita S; Sakamoto J; Sugiyama H; Kimura T
J Cancer Res Clin Oncol; 2013 Mar; 139(3):457-63. PubMed ID: 23160854
[TBL] [Abstract] [Full Text] [Related]
13. A preliminary comparison of total skin electron treatment techniques to demonstrate the application of a mid-torso phantom for measurement of dose penetration.
Baugh G; Al-Alawi T; Fletcher CL; Mills JA; Grieve RJ
Br J Radiol; 2011 Dec; 84(1008):1125-30. PubMed ID: 21304004
[TBL] [Abstract] [Full Text] [Related]
14. A phase I/II trial of a wt1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data.
Morita S; Oka Y; Tsuboi A; Kawakami M; Maruno M; Izumoto S; Osaki T; Taguchi T; Ueda T; Myoui A; Nishida S; Shirakata T; Ohno S; Oji Y; Aozasa K; Hatazawa J; Udaka K; Yoshikawa H; Yoshimine T; Noguchi S; Kawase I; Nakatsuka S; Sugiyama H; Sakamoto J
Jpn J Clin Oncol; 2006 Apr; 36(4):231-6. PubMed ID: 16611662
[TBL] [Abstract] [Full Text] [Related]
15. [Report of the National Oncology Research and Developement Consortium, 2003].
Tímár J
Magy Onkol; 2004; 48(1):75-9. PubMed ID: 15105900
[TBL] [Abstract] [Full Text] [Related]
